Breaking news! Rosiglitazone and cardiovascular risk

被引：0
|
作者：
Sanjay Kaul
George A. Diamond
机构：
[1] Cedars-Sinai Medical Center,Division of Cardiology
来源：
Nature Reviews Cardiology | 2010年 / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the past 3 years, several studies have reignited the controversy regarding the cardiovascular risk associated with the use of rosiglitazone. Until a prospective, well-controlled, randomized clinical trial is performed to adjudicate the issue definitively, physicians should be free to exercise clinical judgment, and weigh the comparative risks and benefits of agents such as rosiglitazone on a case-by-case basis.
引用
收藏
页码：670 / 672
页数：2
相关论文
共 50 条
  • [1] DIABETES Breaking news! Rosiglitazone and cardiovascular risk
    Kaul, Sanjay
    Diamond, George A.
    NATURE REVIEWS CARDIOLOGY, 2010, 7 (12) : 670 - 672
  • [2] Rosiglitazone and cardiovascular risk
    Psaty, Bruce M.
    Furberg, Curt D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24): : 2522 - 2524
  • [3] Rosiglitazone and Cardiovascular Risk
    Kaul, Sanjay
    Diamond, George A.
    CURRENT ATHEROSCLEROSIS REPORTS, 2008, 10 (05) : 398 - 404
  • [4] Rosiglitazone and Cardiovascular Risk
    Kintscher, U.
    KARDIOLOGE, 2007, 1 (02): : 139 - 141
  • [5] Rosiglitazone and cardiovascular risk
    Sanjay Kaul
    George A. Diamond
    Current Atherosclerosis Reports, 2008, 10 : 398 - 404
  • [6] Rosiglitazone and cardiovascular risk - Reply
    Psaty, Bruce M.
    Furberg, Curt D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (09): : 940 - 940
  • [7] Cardiovascular risk of rosiglitazone: another perspective
    Waksman, Javier C.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 (12) : 1573 - 1582
  • [8] Rosiglitazone and the Risk of Adverse Cardiovascular Outcomes
    Winterstein, A. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 776 - 778
  • [9] Is There Clear and Convincing Evidence of Cardiovascular Risk with Rosiglitazone?
    Kaul, S.
    Diamond, G. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 773 - 776
  • [10] Rosiglitazone effects on cardiovascular risk factors and ischemia
    Raji, A
    Di Carli, M
    Seidl, K
    Stone, P
    Plutzky, J
    DIABETES, 2003, 52 : A472 - A472
12345